000 | 01594 a2200445 4500 | ||
---|---|---|---|
005 | 20250517032402.0 | ||
264 | 0 | _c20160921 | |
008 | 201609s 0 0 eng d | ||
022 | _a1098-2744 | ||
024 | 7 |
_a10.1002/mc.22318 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSrinivasan, Asha | |
245 | 0 | 0 |
_aQuercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer. _h[electronic resource] |
260 |
_bMolecular carcinogenesis _cMay 2016 |
||
300 |
_a743-56 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aQuercetin _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_abeta Catenin _xmetabolism |
700 | 1 | _aThangavel, Chellappagounder | |
700 | 1 | _aLiu, Yi | |
700 | 1 | _aShoyele, Sunday | |
700 | 1 | _aDen, Robert B | |
700 | 1 | _aSelvakumar, Ponniah | |
700 | 1 | _aLakshmikuttyamma, Ashakumary | |
773 | 0 |
_tMolecular carcinogenesis _gvol. 55 _gno. 5 _gp. 743-56 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/mc.22318 _zAvailable from publisher's website |
999 |
_c24895587 _d24895587 |